MYCN anticorps

N° du produit ABIN6940152

Détail du produit anti-MYCN anticorps

Antigène: MYCN (N-Myc Proto-Oncogene Protein (MYCN))

Reactivité: Humain, Souris, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MYCN est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Purification: Purified by Protein A/G

Immunogène: Recombinant full-length human n-Myc protein.

Clone: NMYC-1

Isotype: IgG2a kappa

Information d'application

Indications d'application:

Positive Control: 293T whole cell lysates or recombinant Human n-Myc protein.

Known Application: Immunofluorescence (0.5-1 μg/mL), Western Blot (0.5-1.0 μg/mL)Optimal dilution for a specific application should be determined.

Restrictions: For Research Use only

Stockage

Concentration: 200 μg/mL

Buffer: 10 mM PBS with 0.05 % BSA & 0.05 % azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-80 °C

Stockage commentaire: Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Date de péremption: 24 months

Détails sur MYCN

Antigène: MYCN (N-Myc Proto-Oncogene Protein (MYCN))

Autre désignation: MYCN (MYCN Produits)

Synonymes: anticorps MODED, anticorps MYCNOT, anticorps N-myc, anticorps NMYC, anticorps ODED, anticorps bHLHe37, anticorps Nmyc, anticorps Nmyc-1, anticorps Nmyc1, anticorps c-nmyc, anticorps Nmuc1, anticorps fb57a02, anticorps nmyc1, anticorps wu:fb57a02, anticorps zgc:85706, anticorps XN-myc, anticorps XNmyc, anticorps mycn, anticorps mycn-a, anticorps mycn-b, anticorps mycna, anticorps xN-myc1, anticorps MYCN proto-oncogene, bHLH transcription factor, anticorps v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, anticorps v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived, anticorps olfactory receptor 8S1, anticorps MYCN proto-oncogene, bHLH transcription factor S homeolog, anticorps MYCN, anticorps Mycn, anticorps LOC515887, anticorps mycn, anticorps mycn.S

Sujet: The v-Myc oncogene, initially identified in the MC29 avian retrovirus, causes myelocytomas, carcinomas, sarcomas and lymphomas, and belongs to a family of oncogenes conserved throughout evolution. In humans, the family consists of five genes: c-Myc, N-Myc, R-Myc, L-Myc and B-Myc. Amplification of the N-Myc gene has been found in human neuroblastomas and cell lines. Its amplification correlates well with the stage of neuroblastoma disease. Immunological studies have shown that the human N-Myc gene encodes a nuclear phosphoprotein that exhibits relatively short (30 min) half life in vivo. The prototype member of the family, c-Myc p67, binds DNA in a sequence-specific manner subsequent to dimerization with a second basic region helix-loop-helix leucine zipper motif protein, designated Max.

Poids moléculaire: 67kDa

ID gène: 4613

UniProt: P04198